Previous 10 | Next 10 |
On March 26th, Provention Bio announced that the FDA accepted the BLA submission of Teplizumab for the delay of type 1 diabetes (T1D) indication for at-risk individuals. The goal date for PDUFA is August 17th. Until then, there is no meaningful catalyst, meaning the stock could trade ...
iShares Nasdaq Biotechnology ETF (IBB) - $0.1175. 30-Day SEC Yield of 0.31% as of Feb. 28. Payable Mar 30; for shareholders of record Mar 25; ex-div Mar 24. For further details see: iShares Nasdaq Biotechnology ETF declares quarterly distribution of $0.1175
Blackrock outlined its plan to launch the iShares Neuroscience and Healthcare ETF in a U.S. Securities Exchange Commission filing that was put together on Wednesday. The new iShares fund will offer the investment community access to equity securities that are involved in the research, develop...
The gap between the 2-year Treasury yield (NASDAQ:SHY) and the 10-year Treasury yield (NYSEARCA:TBT) (NASDAQ:TLT) is below 20 basis points for the first time this cycle, but likely won't turn negative in 2022, J.P. Morgan strategist Marko Kolanovic says. Investors are concerned with an "...
We are initiating AVDL at a speculative buy rating, with a target price of USD 14. We like AVDL's lead candidate FT218, and we believe the upcoming PDUFA on March 31st to be the critical catalyst for the company. We believe AVDL will be able to generate USD ~300M peak sales. ...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
The SPDR S&P Biotech ETF (NYSEARCA:XBI) is on pace for its best trading week in 21 months as the exchange traded fund earlier this week hit a 23-month trading low. XBI is now +8.2% and +2.6% for the day. The biotech fund had not seen such bullish weekly moves since Jun...
The XBI biotech index peaked early last year, and it's now back to where it was in April of 2020. The biopharma stocks got powerfully inflated during 2020 by the pandemic. The biotech stocks are going to need some good news to get moving again. For further details see: B...
After poor performance during 2015 to 2018, IXJ reshuffled its portfolio. Price return in the past 3 years is good and even better in the longer period. Price multiples suggest that IXJ is neither undervalued nor overvalued. For further details see: IXJ: A Healthcare ETF...
Inflation and its implications for real economic growth are the main portfolio positioning consideration of the conflict in Ukraine. On the 8th of March, the U.S. sanctioned Russian energy imports, giving companies 45 days to comply. Higher commodity prices are not the only factor...
News, Short Squeeze, Breakout and More Instantly...
iShares Biotechnology ETF Company Name:
IBB Stock Symbol:
NASDAQ Market:
2024-07-19 00:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-28 22:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...